Author:
Park Mi Hee,Jo Miran,Won Dohee,Song Ho Sueb,Song Min Jong,Hong Jin Tae
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry (medical),Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference48 articles.
1. Koschny R, Walczak H, Ganten TM (2007) The promise of TRAIL: potential and risks of a novel anticancer therapy. J Mol Med 85:923–935
2. Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8:782–798
3. Bin L, Thorburn J, Thomas LR, Clark PE, Humphreys R, Thorburn A (2007) Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem 282:28189–28194
4. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY et al (2001) Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin’s lymphoma. Oncogene 20:399–403
5. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S (1999) Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59:734–741
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献